Literature DB >> 15163447

Bright light therapy in seasonal affective disorder--does it suffice?

Edda Pjrek1, Dietmar Winkler, Jürgen Stastny, Anastasios Konstantinidis, Angela Heiden, Siegfried Kasper.   

Abstract

Bright light therapy (BLT) has been proposed as treatment of choice for seasonal affective disorder (SAD). However, conventional antidepressants have also been found to be effective in this condition. We examined the psychopharmacologic medication in a clinical sample of 553 SAD patients, who had been treated with BLT, to assess the importance of drug treatment and to critically question the effectiveness of BLT. Forty-nine percent of our patients received psychopharmacologic treatment and about one third (35.4%) was treated with antidepressants, suggesting that BLT does not suffice as only antidepressant regimen for all SAD patients. Furthermore, our results show that only few patients with bipolar affective disorder were willing to accept long-term medication. Opposed to treatment guidelines, patients with several depressive episodes did not receive antidepressant maintenance medication or mood stabilizers more often than patients with only a few episodes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15163447     DOI: 10.1016/j.euroneuro.2003.11.003

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  8 in total

1.  Seasonal affective disorder: an overview and update.

Authors:  Kathryn A Roecklein; Kelly J Rohan
Journal:  Psychiatry (Edgmont)       Date:  2005-01

2.  Report of two double-blind randomized placebo-controlled pilot studies of a carbohydrate-rich nutrient mixture for treatment of seasonal affective disorder (SAD).

Authors:  David Mischoulon; Paola Pedrelli; Judith Wurtman; Mark Vangel; Richard Wurtman
Journal:  CNS Neurosci Ther       Date:  2009-09-21       Impact factor: 5.243

3.  General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry.

Authors:  Thomas C Baghai; Pierre Blier; David S Baldwin; Michael Bauer; Guy M Goodwin; Kostas N Fountoulakis; Siegfried Kasper; Brian E Leonard; Ulrik F Malt; Dan Stein; Marcio Versiani; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-11       Impact factor: 5.270

4.  On the application of light therapy in German-speaking countries.

Authors:  Reinhard Fischer; Siegfried Kasper; Edda Pjrek; Dietmar Winkler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-01-07       Impact factor: 5.270

Review 5.  Long-term and preventative treatment for seasonal affective disorder.

Authors:  Asa Westrin; Raymond W Lam
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

6.  Agomelatine in the treatment of seasonal affective disorder.

Authors:  Edda Pjrek; Dietmar Winkler; Anastasios Konstantinidis; Matthäus Willeit; Nicole Praschak-Rieder; Siegfried Kasper
Journal:  Psychopharmacology (Berl)       Date:  2006-12-15       Impact factor: 4.530

7.  Transcranial bright light treatment via the ear canals in seasonal affective disorder: a randomized, double-blind dose-response study.

Authors:  Heidi Jurvelin; Timo Takala; Juuso Nissilä; Markku Timonen; Melanie Rüger; Jari Jokelainen; Pirkko Räsänen
Journal:  BMC Psychiatry       Date:  2014-10-21       Impact factor: 3.630

8.  Blue Light Deprivation Produces Depression-Like Responses in Mongolian Gerbils.

Authors:  Hong Hu; Chenping Kang; Xiaohong Hou; Qi Zhang; Qinghe Meng; Jianjun Jiang; Weidong Hao
Journal:  Front Psychiatry       Date:  2020-04-08       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.